Ascendis Pharma completes public offering with gross proceeds of USD 345 million

Mazanti-Andersen advises long-term client Ascendis Pharma A/S in connection with its underwritten public offering of 2,300,000 American Depositary Shares (ADSs).

Ascendis Pharma A/S recently completed its public offering with gross proceeds of USD 345 million.

Mazanti Transactions acted as Danish legal counsel to long term client Ascendis Pharma with a team comprising of Lars Lüthjohan and Gyrithe Falck.